KEAP1 and Parkinson disease: Furthermore, through molecular docking and mouse model studies, we have unraveled the interactions between LRRK2 and the p62-Keap1-Nrf2 pathway, laying a solid foundation for understanding the pathological mechanisms of Parkinson’s disease and developing targeted therapeutic strategies for LRRK2.